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Abstract 
The characterization of complex diseases remains a great challenge for biomedical 
researchers due to the myriad interactions of genetic and environmental factors. Adaptation of 
phylogenomic techniques to increasingly available genomic data provides an evolutionary 
perspective that may elucidate important unknown features of complex diseases. Here an 
automated method is presented that leverages publicly available genomic data and phylogenomic 
techniques. The approach is tested with nine genes implicated in the development of Alzheimer 
Disease, a complex neurodegenerative syndrome. 
The developed technique, which is an update to a previously described Perl script called 
“ASAP,” was implemented through a suite of Ruby scripts entitled “ASAP2,” first compiles a list 
of sequence-similarity based orthologues using PSI-BLAST and a recursive NCBI BLAST+ 
search strategy, then constructs maximum parsimony phylogenetic trees for each set of nucleotide 
and protein sequences, and calculates phylogenetic metrics (partitioned Bremer support values, 
combined branch scores, and Robinson-Foulds distance) to provide an empirical assessment of 
evolutionary conservation within a given genetic network. 
This study demonstrates the potential for using automated simultaneous phylogenetic 
analysis to uncover previously unknown relationships among disease-associated genes that may 
not have been apparent using traditional, single-gene methods. Furthermore, the results provide 
the first integrated evolutionary history of an Alzheimer Disease gene network and identify 
potentially important co-evolutionary clustering around components of oxidative stress pathways. 
 
  
Introduction 
 Classical genetic diseases typically arise due to isolated genetic changes within a single 
gene or allele (Badano & Katsanis, 2002). Many of these “simple” or “monogenic” diseases 
follow Mendelian patterns of inheritance. The responsible genetic lesion is often the result of an 
insertion or deletion event, or the transversion / transposition of a nucleotide. The probability for 
transmission of simple genetic disorders may thus be easily predicted and generally follow sex-
linked or autosomal patterns of heredity. Classic examples of monogenic disorders include cystic 
fibrosis, sickle cell anemia, and achondroplasia (Velinov et al., 1994; Kerem et al., 1989; Rees et 
al., 2010). By contrast, complex diseases or disorders may not follow clear hereditary patterns or 
be diagnosed based on isolated genetic lesions.  However, many complex diseases such as 
cardiovascular disease, type 2 diabetes mellitus, and Alzheimer disease occur with higher 
frequency among families and close genetic relatives– suggesting that the interaction of genetic 
elements may play a central role in their pathogenesis, beyond environmental or behavioral 
factors (Sillén et al., 2006). Identifying risks for complex diseases and developing new 
approaches for treating or preventing them may benefit from high-throughput, computational, or 
bioinformatics based approaches. For example, computational approaches, such as used in 
Genome Wide Association Studies (GWAS), exome sequencing, proteomics, and microarray 
analyses, have shown great promise in recent years. Related advances in biotechnology have 
facilitated the identification of genotypes that may be factors involved in the heritability of 
complex genetic diseases (Yonan et al., 2003). For example, specific genotypes can be associated 
with a probabilistic value of susceptibility relative to the gene(s) they influence and thus 
correlated with a disease phenotype (Badano & Katsanis, 2002; Li et al., 2005; Newton-Cheh et 
al., 2009; Klein et al., 2012).  
 Due to a lack of knowledge about the specific mechanisms by which multiple genetic 
factors may influence complex diseases, pharmacotherapies are often aimed at managing 
symptoms or laboratory values, and are thus reactionary and not curative. Thus, the approach to 
complex disease management necessarily extends beyond pharmacotherapy, attempting 
environmental and behavioral changes through patient education or lifestyle modification 
(Estruch et al., 2013).  A major current goal of biomedical research is therefore to better 
characterize the complex factors that contribute to developing complex diseases and identify new 
targets for therapeutic intervention. The fact that the genetic environment influences 
susceptibility to complex disease implicates the structural or functional relationships between 
some or all members of a disease associated gene network in the development of the disease (Li 
et al., 2005). This relationship might be a direct physical interaction between the protein products 
of the genes, parallel functionality in metabolic pathways, or co-localization of protein products 
in a certain cell or tissue type (Li et al., 2005). These data are not easily elucidated using an 
experimental approach focused on a single gene or pathway and require a broader systems-based 
methodology. These types of relationships may be reflected in the evolutionary conservation of 
genes or gene groups among organisms with and without susceptibility to a given disease 
(Thornton & DeSalle, 2000; Sillén et al., 2006; Watson et al., 2014). Mapping the evolutionary 
patterns of gene conservation or co-evolution associated with a complex disease may identify 
previously unknown clusters of genes or functional pathways that have impact on a disease 
process. 
 
 
 
Simultaneous Analysis  
 Phylogenetic analyses infer potential evolutionary relationships based on similarities 
implying common descent from shared ancestry and are performed on data sets consisting of 
physical, functional, or molecular representations (Swiderski et al., 1998; Yonan et al., 2003). 
Genomic analyses typically construct the analytic matrix using nucleotide or amino-acid 
sequences from different individuals or species (termed “taxa”; singular “taxon”). Classically, the 
resulting data are presented as trees where the branching points (termed “nodes”) give rise to 
hierarchical groupings of more similar taxa (akin to leaves on a branch). These trees can be used 
to explore potential patterns of divergence from a common ancestor as well as the degree of 
difference among taxa included in the tree. This degree of difference is usually described as an 
evolutionary “distance” that can be inferred multiple ways, but typically represents a measure of 
evolutionary change (based upon sequence differences) or an amount of time since divergence 
likely occurred (Zharkikh, 1994; Hedges et al., 2006).  
However, like experiments focused on a single gene or pathway, an isolated phylogenetic 
analysis may not capture important features of co-evolution or conservation of gene clusters 
impacting complex disease processes.  Additionally, reliance on phylogenetic trees of individual 
genes may not fully address the potential for genetic changes such as lateral gene transfer, 
reversion of mutations, or recombination events (Dagan, 2011; Layeghifard et al., 2013).  
To account for multiple evolutionary patterns represented by multiple genes, data matrices 
can be combined into a single phylogenetic analysis through a “simultaneous analysis” (SA) 
approach (Nixon & Carpenter, 1996; Gatesy et al., 1999; Rokas et al., 2003). In SA, individual 
data blocks (e.g., a sequence matrix for a particular gene; referred to as a “partition”) are 
systematically combined to enable higher-order analyses that transcend data derived from 
analysis of an individual partition. Frequently, SA values are derived by applying arithmetic 
operations on other (already determined) SA values, so the workflow tends to follow a stepwise 
pattern. Previous studies have shown that SA techniques strengthen the overall support for the 
evolutionary patterns represented by trees determined by single partition phylogenetic analyses 
(Baker et al., 1998). 
In this study, a previous automated SA approach (Automated Simultaneous Analysis 
Phylogenetics; ASAP (Sarkar et al., 2008)) was refined to collect and analyze disease genes 
based on: (1) the degree of corroboration between partitions; and (2) the support for an overall 
consensus tree modeling a putative evolutionary relationship common to all partitions, using 
maximum parsimony analysis (Fitch, 1971). The final phase then generates a phylogenetic 
network based on the Robinson-Foulds tree similarity metric (Robinson & Foulds, 1981).  
 
Alzheimer Disease 
Alzheimer Disease (AD), a complex neurodegenerative disorder, is the most common 
form of dementia, accounting for between 70 – 90% of diagnosed cases of dementia (Ferri et al., 
2005; Mayeux & Stern, 2012). Worldwide, more than 24 million people are estimated to have 
AD, with estimates exceeding 80 million to be affected over the next 30 years (Ballard et al., 
2011)  The pathognomonic histological finding that originally defined AD is the presence 
amyloid plaques in cortical brain tissues (Hardy & Selkoe, 2002; Nelson et al., 2009; 2012). The 
plaques arise from the production, and eventual extracellular precipitation, of fibrillar aggregates 
of amyloid-β peptides causing disruption of the neural architecture and induction of inflammation 
(Hardy & Selkoe, 2002). Clinically, AD is characterized by progressive memory loss and 
cognitive decline, leading to general functional impairment (Blacker et al., 1994; Dubois et al., 
2007; Querfurth & LaFerla, 2010; Karran et al., 2011; Nelson et al., 2009; 2012). However, the 
precise etiology of AD remains elusive. Amyloid plaques have been shown to differ widely in 
manifestation with regards to protein composition, structural characteristics, and prevalence 
(Silverman et al., 1999; Lu et al., 2013). Despite advances in predicting the presence of the 
disease based on symptoms and diagnostic imaging, a definitive diagnosis of AD can only be 
made after an autopsy of the affected brain after death (Blacker et al., 1994; Dubois et al., 2007). 
As such, researchers are faced with significant difficulties both in studying the progression of the 
disease as well as identifying potential therapeutic techniques to prevent or treat the disease. 
Further compounding the difficulty in identifying causes of AD is the fact that the 
majority of cases do not follow a well-characterized pattern of heritability, even though 
susceptibility to AD is widely considered to have a genetic basis (Sjögren et al., 1952; Silverman 
et al., 1999; McIlroy et al., 2000; Ramanan et al., 2013). Familial forms of AD have been 
identified resulting from single or double gene lesions leading to increased amyloid plaque 
burden, but these account for less than 5% of the total cases of AD (Tanzi, 2012). Over the course 
of decades of study, a wide range of human genes have been linked to susceptibility at various 
stages of life, suggesting sporadic AD has a multifactorial, complex genetic component (Tanzi, 
2012).  Finally, rodent models of AD rely heavily on genetic manipulation to recapitulate the 
pathological findings in humans, suggesting evolutionary changes in the genetic environment 
among organisms may be protective or permissive for the development of AD. 
Network medicine describes the rise of disease phenotypes as perturbations in the normal 
interactions of molecular, environmental, and population networks rather than a single 
macromolecule or biological pathway (Barabási et al., 2011).  This approach may be especially 
important for complex diseases where numerous genetic events or environmental factors may 
contribute to similar phenotypic results in one class of organism but not in another.  The use of 
evolutionary models extends this approach to include ancient environmental and population data 
into the construction of a disease network and may identify both previously unknown factors 
contributing to disease development and new model organisms for understanding disease 
pathology.  SA inherently considers all aspects of multiple genetic factors that may be working in 
concert. Thus, AD is a perfect candidate disease for testing the potential utility of SA techniques. 
The overall goal of this study was to develop an automated method for an SA 
phylogenetic analysis and to use it to construct an evolutionary history for a set of genes that may 
be correlated with AD. The co-evolution was examined for nine genes previously identified as 
associated with AD susceptibility using a SA technique mediated with a series of scripts written 
in the Ruby scripting language. The resulting phylogenetic tree provides the first description of 
the co-evolution of genes that may impact the development and pathogenesis of AD. The 
resulting phylogenetic network further highlights a potentially important role of oxidative stress 
genes in the evolution of the AD gene network. The developed technique provides a framework 
for an automated approach to study the co-evolution of gene sets associated with a complex 
disease using a robust phylogenetic methodology. 
 
Materials and Methods 
The automated collection and simultaneous phylogenetic analysis process was developed 
using a sequential set of Ruby (Matsumoto, n.d.) scripts (entitled and referred to henceforth as 
“ASAP2”) that made use of the Bioruby gem (Goto et al., 2010) as well as the following freely 
available genomic or phylogenetic analysis tools: BLAST+ (Basic Local Alignment Search Tool 
(Camacho et al., 2009)), MUSCLE (MUltiple Sequence Comparison by Log-Expectation (Edgar, 
2004)), and TNT (Tree analysis using New Technology (Goloboff et al., 2000)) . The overall 
workflow for ASAP2 is shown in Figure 1. ASAP2 is an improvement over an earlier version of 
the implemented approach, ASAP, which was written as a single Perl script. 
  
Alzheimer Disease Gene Sequences  
Nucleotide sequences for genes implicated as contributing to a higher risk for Alzheimer 
Disease (AD) in humans were manually identified using the data associated with the “Alzheimer 
Disease; AD” entry in Online Mendelian Inheritance in Man (OMIM) (OMIM ID #104300) 
(McKusick, 2007). This yielded ten discrete genes shown to be related to AD, which were loaded 
into ASAP2. For the purposes of this study, nonspecific chromosomal regions that encompass 
numerous genes or the noncoding regions between them were not included.  
 
Identifying Potentially Related Disease Genes Based on Sequence Similarity 
 From the initial set of human AD disease gene sequences, ASAP2 performed two types of 
sequence searches from within the non-redundant (nr) protein database maintained at the United 
States National Library of Medicine’s National Center for Biotechnology Information (NCBI) 
using NCBI BLAST+ (Camacho et al., 2009). First, a PSI-BLAST (Position-Specific Iterated 
BLAST) search (which searches for similar sequences using an iterative profiling approach 
(Altschul et al., 1997)) was done for each gene sequence. Second, a recursive search was initiated 
with a BLASTx (which uses a translated nucleotide sequence query to perform a protein search) 
search of the nr protein database for the gene of interest and the best results used to iteratively 
search for additional protein sequences using BLASTp (which searches for protein sequences 
using an amino-acid query) until no additional sequences were found. An expect value (E-value) 
of 1.0×10-256 was used as the criterion for inclusion of results for both the PSI-BLAST and the 
recursive BLAST algorithm. Candidate data partition matrices for each gene were then 
constructed based on the combination of PSI-BLAST and recursive BLAST results. 
Corresponding nucleotide sequences were determined based on information in the DBSOURCE 
metadata field that links a given protein sequence to its coding nucleotide sequence. 
 After candidate data partitions were assembled, ASAP2 culled taxa and sequences from 
each data partition that were not uniformly represented for each gene (i.e., a sequence for a given 
species must be present in each data partition for that species to be retained for further analysis). 
Additionally, if any species was represented more than once in any partition, ASAP2 only kept 
the first (most similar according to BLAST) protein sequence for that species. ASAP2 then 
assembled the resulting data partitions into FASTA files, aligned them using the default 
parameters of MUSCLE, and formatted them into TNT-compatible data matrix files. ASAP2 also 
includes the ability to align sequences using MAFFT or Clustal Omega, which are packaged 
alongside MUSCLE and may be specified using arguments at runtime. Additionally, the user has 
the ability to provide sequences aligned through other means (including manually). For the 
purpose of this study, and to demonstrate the automated capabilities of ASAP2, all sequences 
were aligned using the default MUSCLE strategy. The generated FASTA files and TNT data 
matrix files are available as Supplementary Data. 
Sequence length was manually verified following the selection of sequences, prior to 
conducting simultaneous analysis. As the SA techniques implanted in ASAP2 do not require a 
distinction between orthologues and paralogues, this was done only with the intent of preventing 
the use of large chromosomal assemblies or very short gene fragments. Additionally, the 
BLAST2 expect value between each pair of sequences in each partition was computed to verify 
that all sequences are statistically similar to one another; No maximum expect value was used as 
a cutoff, but all values were smaller than 1x10-100. 
 
Phylogenetic Analyses 
 ASAP2 used TNT to conduct the maximum parsimony phylogenetic analyses of each data 
partition. Trees were constructed using tree bisection and reconnection (TBR) rearrangement, 
finding optimal scores 20 times followed by 10 cycles of tree-drifting. Subsequently, group 
support values were determined by counting the minimum number of steps needed to lose each 
group by TBR rearrangement (Goloboff & Farris, 2001). The TNT analysis included individual 
plotting of apomorphies and synapomorphies, bootstrap resampling, and calculation of both the 
relative and absolute Bremer support values at each branch.  
ASAP2 then generated a SA consensus tree using TNT by creating an interleaved matrix 
of the data partitions. The interleaved matrix was built by concatenating each aligned data 
partition (minus headers and metadata) sequentially, separated by line breaks, into a single TNT 
data file. This data file was then interpreted by TNT as if the sequences for each species were 
concatenated in the order of the data partitions in the interleaved matrix. The tree building routine 
was the same as used for analyzing the individual data partitions, except 30 cycles of tree-drifting 
were used. 
The Partitioned Bremer Support (PBS; also known as Partitioned Branch Support) at each 
node in the SA consensus tree was used as the primary criterion for the evaluation of each data 
partition. The PBS value is defined as "the minimum number of character steps for [a] partition 
on the shortest topologies for the combined data set that do not contain that node, minus the 
minimum number of character steps for that partition on the shortest topologies for the combined 
data set that do contain that node" (Gatesy et al., 1999). Therefore, a specific PBS value can be 
interpreted as a measurement of how well the data from a particular partition either support 
(represented by positive values) or refute (negative values) a particular node on the consensus 
tree. Branch Support (BS) values, defined as "the minimum number of character steps for that 
data set on the shortest topologies that do not contain that node, minus the minimum number of 
character steps for that data set on the shortest topologies that contain that node" were used as the 
second criterion for evaluation of the SA consensus tree (Gatesy et al., 1999). After determining 
PBS values across all tree nodes on the consensus tree for each data partition, the BS was 
determined for each node on the consensus tree by the sum of all PBS values for that particular 
node. A positive BS score indicates that the overall combined set of data partitions support the 
topology at that node rather than refute it. ASAP2 uses a slightly modified version of a previously 
developed TNT script to calculate the PBS values (Peña et al., 2006). Modifications were made to 
the original TNT script were to facilitate automated data input and processing of output as 
required by ASAP2 without altering the tree building routines, and minimizing the text-based 
front end displayed to the user. 
The Hidden Branch Support (HBS) for a particular node on the consensus tree was 
computed as the difference between the BS value at that node in the consensus tree and the sum 
of the BS values for that node from each data partition. The magnitude of an HBS value of a 
given node in the consensus tree was used as the final criterion for determining the overall 
strength of supporting or refuting the topology at the node.  
Finally, a phylogenetic network was generated from the consensus analyses for each data 
partition using the Robinson-Foulds (RF) metric to quantify the distance between each pair of 
trees (Robinson & Foulds, 1981).  This was implemented using a previously written TNT script 
(Goloboff, n.d.) that was modified to fit within the automated workflow of ASAP2. All 
calculations and parameters in the script were unchanged from the original version. To transform 
RF values onto a scale where larger values corresponded to more similarity (conventionally, 
higher RF values indicate greater dissimilarity based on a normalized count of symmetric 
differences between trees), the following calculation was used: 
𝑅𝐹! = 1𝑒!" 
Cytoscape (Smoot et al., 2011) was then used to visualize the network relationship among the 
gene trees based on the RF’ values as normalized edge weights using a force-directed layout. 
 
Establishing a Benchmark for ASAP2 
ASAP2 was run using the mitochondrial genes for the 34 species included in the AD study, 
where the data partitions were constructed from the protein and translated nucleotide sequences 
for mtDNA genes.  The gene clustering diagrams based on the RF’ values for the mtDNA 
analysis were viewed individually, and again when ASAP2 was run using the gene partitions 
from both the AD study and the mtDNA genomes. A visual comparison of the diagrams was used 
to qualitatively interpret the strength of the conclusions made by the AD analysis alone. 
  
Results 
 
ASAP2 
ASAP2 was developed as a set of Ruby scripts and is available at GitHub under the GNU 
General Public License (https://github.com/UVM-BIRD/asap2). The script guides the process of 
performing a SA from an initial set of Genbank identifiers. By the end of the analysis, ASAP2 
produces files containing the data partitions, E-value tables, FASTA files of the final data 
partitions (both unaligned and aligned), TNT data matrices, and all TNT output, including log 
files and parenthetically-notated tree files. The ASAP2 data workflow is illustrated in Figure 1. 
 
Gathering Uniform Taxonomic Distribution of AD Genes  
Ten genes associated with Alzheimer Disease susceptibility were initially selected 
through and OMIM for analysis using ASAP2. Due to incompatibility issues with BLASTx, one 
gene (PAX-interacting protein 1 [PAXIP1]; GI:530387259) was removed from the analysis. In 
brief, because PAXIP1 contains six BRCT (BRCA C terminus) domains that are homologous to 
many sequences in GenBank, BLASTx quit at each attempt due to memory overflow. The nine 
remaining genes used for the remainder of the study are listed in Table 1. 
The combined PSI-BLAST and recursive BLAST results for each gene included in this 
study resulted in nine data partitions representing 34 unique species (including Homo sapiens; 
Table 2). If the BLAST analyses resulted in any species being represented more than once in a 
data partition, only the first sequence (the one most similar to the query sequence) was kept. The 
protein sequences identified, along with the corresponding source nucleotide sequences, using 
this process are provided in Supplementary Table 1.  
 
Simultaneous Analysis 
 All phylogenetic analyses were rooted to Dasypus novemcinctus (nine-banded armadillo), 
which was determined to be the furthest diverged from humans using TimeTree (Hedges et al., 
2006). Individual maximum parsimony trees for each nucleotide and protein data partition are 
shown in Figure 2 and Figure 3, respectively. Consensus SA trees based on the combination of 
the nine data partitions are shown in Figure 4 and Figure 5 (nucleotide and protein tree, 
respectively). Computed Branch Score (BS) values are shown on the consensus trees, and 
corresponding Partitioned Bremer Support (PBS) values are listed in Table 3 and Table 4, 
respectively.  
 Individual trees for the respective nucleotide and protein data partitions yielded an 
evolutionary lineage for each individual gene, but empirical comparison of partition trees did not 
show coherent patterns. However, the SA trees did show a distinct branching pattern, with no 
more than two branches emerging at any single node. Furthermore, while some PBS values were 
negative (indicating that the data in a specific partition was not congruent with the consensus tree 
at that branch), all the BS values on the protein SA tree were positive. The nucleotide SA tree had 
positive BS scores at each node with no polytomies, suggesting that the genes selected for this 
study supported all the internal branches in the protein simultaneous analysis tree. 
 While the topologic organization of the SA trees generally followed canonical patterns of 
mammalian evolution there were some notable exceptions that received high levels of statistical 
support. In the SA nucleotide tree, most primates were grouped together into the monophyletic 
clade rooted at node 13, with the exception of Macaca mulatta (rhesus macaque), Callithrix 
jacchus (common marmoset) and Otolemur garnettii (northern greater galago) that each occurred 
distally from all other primates (Figure 4). In the SA protein tree, primates were divided into two 
distinct clades: (1) a monophyletic clade rooted at node 27, or (2) a paraphyletic clade rooted at 
node 8 that also included Sus scrofa (wild boar) and Jaculus jaculus (lesser Egyptian 
jerboa)(Figure 5).  
 
 
Comparison of Trees Using the Robinson-Foulds Metric  
 The Robinson-Foulds metric was used to quantify the similarity between the generated 
trees. The pairwise comparisons between each of the nucleotide and protein data partitions are 
shown in Table 5 and Table 6, respectively. Additionally, the RF (and RF’) distances for 
respective nucleotide and protein trees for a given partition as well as for the SA trees are shown 
in Table 7. The RF’ distances were used as input into CytoScape to visualize the relative 
relationship between nucleotide and protein sequences for a given gene based on shared 
evolutionary history, shown in Figure 6.  The resulting phylogenetic networks showed a tight 
clustering of MPO, A2M, NOS3, SORL1, and PLAU evolutionary patterns. 
 
Comparison of AD Gene Clustering to mtDNA Genes 
 A benchmark for ASAP2 was accomplished by comparing the results for the set of AD 
genes to the corresponding results using sequences for mtDNA genes for the same set of 34 taxa. 
The RF’ gene clustering network diagrams (Figure 7a for protein sequences and Figure 7b for 
nucleotide sequences) for the mtDNA genes alone show relatively tight clustering, with the slight 
exception of the ND4L gene in the protein analysis and the ND6 gene in the nucleotide analysis. 
Overall, this finding recapitulates that mtDNA genes may be suitable as taxonomic markers or for 
species identification. When both mtDNA and AD gene partitions were used in the SA analyses 
(Figures 7c and 7d, for protein and nucleic acid sequences, respectively), the network diagrams 
reveal that the mtDNA genes cluster closely with a number of AD genes that themselves form a 
cluster– namely MPO, A2M, NOS3, SORL1, and PLAU. 
 
 
Discussion 
The use of ASAP2 enabled the generation of the first integrated phylogeny of Alzheimer 
Disease associated genes. The results are robust and generally consistent with accepted patterns 
of taxonomic evolution. Examination of the resultant phylogenetic network also identified a 
clustering of evolution patterns among oxidative stress related genes associated with the 
development of AD. As the results suggest, SA techniques may have utility in development of 
large-scale studies that aim to model the evolutionary development, transmission, and interaction 
of disease associated gene sets.  
 
ASAP2 Function 
ASAP2 consolidates the application of SA techniques into a single pipeline of Ruby 
scripts designed to expose higher-order quantitative relationships between genes not visible 
through more traditional single-gene based analyses. Implementing SA techniques often requires 
a significant amount of manual data curation that is both labor- and time-intensive. ASAP2 was 
designed as a flexible automated tool that performs these tasks with minimal intervention beyond 
entering the initial GenBank identifiers. ASAP2 thus supports the ability to do large-scale 
phylogenetic analyses in a tractable manner. ASAP2 execution time is generally 𝛩(𝑛!) with 
respect to both the number of data partitions and the average length of sequences, but overall 
runtime can be considerably reduced based on available computational resources for individual 
BLAST queries, sequence alignments, and phylogenetic tree search routines. The data structures 
produced by ASAP2 were intentionally designed to be user-readable and manually editable 
during a given analysis. This supports the ability to adjust subsequent analyses based on results 
generated at any point along the analysis pipeline. 
 The original Perl version of ASAP (Sarkar et al., 2008) required a prior file containing 
sequences that was then aligned using MUSCLE and the SA subsequently executed using PAUP* 
(Wilgenbusch & Swofford, 2003). ASAP also allowed for the inclusion of pre-aligned or 
morphological data. By contrast, ASAP2 was developed in Ruby, uses MUSCLE based 
alignment with the SA analyses done in TNT (which is freely licensable, unlike PAUP*). 
Additionally, ASAP2 was specifically designed to work exclusively with molecular data 
available from GenBank/GenPept, requiring only that the user provide an initial set of Accession 
numbers. 
 In this study, the utility of ASAP2 is demonstrated by performing analyses on a discrete 
set of pre-identified disease associated genes. However, the script may also be used for a myriad 
of large-scale multi-gene phylogenetic investigations. For example, one could use ASAP2 to 
study whole genomes with the goal to identify essential, evolutionarily conserved genes in groups 
of species (Rokas et al., 2003; Klein et al., 2012). Conceptually, by adjusting inclusion thresholds 
for the BLAST search mechanism and by specifying different options for the sequence alignment 
procedure, analyses could be expanded for constructing SA networks with respect to entire gene 
families, as opposed to the intention of finding putative orthologues for a single gene (as was 
done in this study).  
 
Putative Orthologue Sequence Identification 
Based on an initial OMIM query for Alzheimer Disease, orthologues for 34 species were 
identified across nine disease genes. In addition to the recursive BLAST based approaches 
implemented by ASAP2, there are specific orthologue resources that could have also been 
searched to identify orthologous sequences for each of the nine disease genes. For example, 
inParanoid (Ostlund et al., 2010) and OrthoMCL (Li et al., 2003) had eight and 13 species 
spanning the nine genes, respectively. Interestingly, in identifying the set of species that contains 
putative orthologues for each of the AD genes through each of the three identification methods, 
ASAP2 and inParanoid identified only mammalian species, while OrthoMCL identified a set of 
organisms that included several non-mammalian species, including Danio rerio (zebrafish), 
Takifugu rubripes (tiger blowfish), Tetraodon nigroviridis (spotted green pufferfish), and Gallus 
gallus (chicken). Additionally, both inParanoid and OrthoMCL identified the species Canis 
familiaris (dog) and Equus caballus (horse), while ASAP2 did not. The differences in orthologue 
identification may be due to the conservative filtering parameters used for BLAST queries in 
ASAP2 that were tuned to ensure a high degree of similarity between sequences and to minimize 
the possibility of random homologies (as implicated by using an E-value of 1.0 x 10-256). Neither 
inParanoid nor OrthoMCL identified the same set of additional species across all nine genes that 
were the focus of this study. ASAP2 does allow for the inclusion or removal of sequences to 
increase or reduce the taxonomic diversity of a given analysis immediately following the BLAST 
analyses; however, since no additional taxa were identified uniformly across the nine genes of 
interest by either OrthoMCL or inParanoid, no such modification of taxon diversity was 
performed in this study. Additionally, future studies may benefit from starting with a wider 
empirical set of genes or with parameters for the recursive BLAST strategy that are tuned to 
higher E-values that could lead to greater taxonomic diversity. 
It should be noted that the ASAP2 sequence identification method does not have the 
ability to definitively distinguish between orthologues and paralogues. However, due to the low 
expect value used in the ASAP2 BLAST search strategy, only highly similar sequences are 
preserved (and, if more than one sequence is found for a given species, only the ‘best’ sequence 
will be kept). Therefore, regardless of whether an identified sequence is an orthologue or an in-
paralogue to a human sequence, the phylogenetic analysis of the sequences should reveal how 
that sequence has evolved across the set of species. In this way, ASAP2 provides a systematic 
mechanism to leverage both similarity-based approaches for sequence identification alongside 
phylogenetic approaches for evolutionary study of those similar sequences.  
 
Phylogenetic Analysis 
The TNT analyses used by ASAP2 were optimized to only include the most unambiguous 
groupings. As such, the TNT scripts produce fewer trees, but the likelihood of the trees reflecting 
evolutionary history is correspondingly more reliable. The final consensus tree represents a likely 
model of evolutionary transmission of the group of Alzheimer Disease genes studied, and the 
partitioned Bremer support values indicate the degree to which each gene fits the predicted 
pattern of evolution. The partitioned Bremer values may also be used to identify genes or species 
in a study that did not (for one reason or another) follow a similar pattern of transmission as the 
others. Topologically, the SA protein tree in this study exhibited a small number of groupings 
that differ from the accepted model of mammalian evolution, notably the separation of primates 
into two distinct clades. On the SA nucleotide tree, the paraphyletic grouping of some primates 
also merits scrutiny since this suggests that the genes included in this study deviate from 
taxonomically accepted evolution. Since only the most similar GenBank-catalogued sequence 
was retained for each species included in this study, there is only a modest risk of accidental 
selection of a paralogue instead of an orthologue; it was presumed that this assumption would not 
significantly impact the structure of the tree for the purposes of this demonstration study. 
However, future studies might benefit from a critical manual review of the ASAP2 selected 
sequences. It is important to note that the aggregate PBS values for these different nodes are low 
and may be subject to topologic changes with the addition of more partitions. However, these 
“alternative” placements of certain primate species in the SA tree might also be explained by a 
reversion to an ancestral state for a particular disease gene. In this instance, the “state” being 
referred to would be patterns of interaction between the disease genes included in the study – the 
SA trees can be thought of as a phylogenetic analysis of the possible network in which some of 
the AD genes may function, and placement on the tree represents nonspecific alterations to that 
network. Likewise, an “ancestral state” would be the structure and genetic landscape of this 
possible network in a common ancestor to the organisms on the tree. Therefore, this type of 
deviation from taxonomic evolution represents potential evolutionary divergence of this theorized 
Alzheimer Disease gene network within isolated species. The presence of these types of alternate 
evolutionary patterns points to potential differential susceptibility of species to the development 
of AD. For example, the APBB2 and APP PBS values at node 13 in the nucleotide SA tree are 
significantly higher than for other partitions: 993 and 986, respectively (compared to average 
values of 131.4 ± 620.1). These values suggest a potential interaction (based on a strongly 
corroborated evolutionary history) between the protein products of APBB2 and APP in primates. 
Building on the known interaction between APBB2 and APP in H. sapiens, exploration of the 
polymorphisms in these genes in M. mulatta and O. garnettii may elucidate the potential for 
differences in functional interactions. Such further exploration of these types of findings, 
especially relative to critical synapomorphic characters, could therefore yield valuable data 
regarding the evolutionarily important functional or potentially interacting sites for a given 
disease gene. 
 The individual data partition protein trees had a high incidence of polytomy, which is 
when more than two species branch off of a single node. This is generally considered 
uninformative in determining ancestry, as there are not enough data to determine whether species 
branching off of the same node are more or less closely related. However, these observations 
highlight the evolutionary conservation of fundamental protein sequences over many related 
organisms (Alexander et al., 2007; Kaneko et al., 1995; Pardossi-Piquard et al., 2005; Liu et al., 
2007; Nikolaev et al., 2009). APP, one of the central genes in Alzheimer Disease research, 
displays the most drastic examples of polytomy, with 17 branches underneath one node alone. 
This reinforces previous studies showing a high degree of conservation of the APP gene family 
over time (Freir et al., 2011; Yang et al., 2011; Manczak & Reddy, 2013; Coulson et al., 2000; 
Tharp & Sarkar, 2013). 
 While the protein phylogenies demonstrate conservation of structure across multiple 
species, the nucleotide sequences generate trees allowing a more precise elucidation of ancestry. 
Since nucleotide sequences can have differences that do not affect protein structure or function 
due to the degeneracy of the genetic code, rates of change in nucleotide sequences are more 
closely tied to evolutionary time (Brown, 2002; Bejerano et al., 2004; McKusick, 2007; Lehmann 
& Libchaber, 2008)). Among the individual partition nucleotide trees, only the APBB2 tree has 
an occurrence of more than two branches rooted at a single parent node. The branch generated at 
this node contains four species of very closely related great apes (N. leucogenys, G. gorilla 
gorilla, P. troglodytes, and P. paniscus). This suggests that the nucleotide sequences 
corresponding to APBB2 in each of these species are so similar that a more descriptive 
phylogenetic relationship between them cannot be determined, which underscores the fact that 
APBB2 is highly conserved among closely related species. 
Determination of the distance between individual trees prior to constructing a consensus 
tree can help to preliminarily identify clustering patterns among specific genes prior to 
constructing a consensus tree (Vilella et al., 2009). Additionally, once a consensus is reached, 
these distances can be used to explain the strength of the support for the SA tree and generate 
representations of the gene network (Degnan et al., 2009). While multiple methods may be used 
to evaluate the distance between trees consisting of the same set of taxa, this study used the 
Robinson-Foulds (RF) distance (Robinson & Foulds, 1981). The RF distance between two trees 
is defined by the sum of the number of data partitions implied by one, but not both, of the trees. A 
variety of algorithms exist for computing RF distance (Bansal et al., 2010; Chaudhary et al., 
2013), and an optimal method is usually selected on the basis of algorithmic complexity and 
worst-case running time (Goloboff & Farris, 2001; Pattengale et al., 2007; Chaudhary et al., 
2012). In this study, a phylogenetic network was constructed based on tree topology similarity 
using RF (transformed to RF’, which converts RF values onto a scale where higher values 
correspond to less similarity). On examination of the phylogenetic network for the Alzheimer 
Disease genes used in this study, a tight clustering of oxidative stress genes was observed with 
the gene for plasminogen activator (PLAU) and a member of the sortilin related receptor gene 
family (SORL1). While SORL1 has been found to have an important association with Alzheimer 
Disease and oxidative stress genes are involved in the unfolded protein response associated with 
increased amyloid formation, a relationship between these genes has not been shown before 
(Rogaeva et al., 2007; Haataja et al., 2008). This type of association is not observable using 
single pathway experiments or phylogenetic methods that do not incorporate an SA approach. 
Further investigation will be needed to understand the nature of this network clustering.  
In interpreting the SA values and the gene-clustering network diagrams, two important 
assumptions regarding network medicine and complex genetic disorders should be noted: (1) 
Although many genetic components may be identified for a given disease, it should not be 
assumed that all of these factors are involved in the same pathway – there may be multiple 
pathways involved; and (2) Coevolution of genes does not necessarily imply conservation due to 
related function, and vice-versa – coevolution may be a result of factors as simple as two genes 
being in close proximity on the same chromosome. These assumptions underscore how the 
information provided by SA techniques and the broader disease implications may be potentially 
misleading or incomplete. Nevertheless, an SA methodology might still provide insights to 
potential targets for clinical therapies that would not have been highlighted using more traditional 
single-gene based analytic approaches. 
 A final aspect of this study is that it further highlights the fact that choice of model 
organism is paramount for the study of complex disease. The relatively short lifespan of M. 
musculus and malleability of the murine genome has led to an explosion of experimental 
approaches centered on manipulation of genes thought to be involved in human disease (Bedell et 
al., 1997a; 1997b). However, especially with relation to complex diseases, alternative model 
organisms need to be considered (Ostrander, 2012). The recent increase in biological systems 
data and continued growth in bioinformatics methodologies for analyzing these data may allow 
for the development of more data driven choices of model organisms for complex diseases. For 
example, based on the preliminary findings of this study of the shared evolution of a limited set 
of genes thought to influence AD susceptibility in humans, the SA consensus trees suggests that 
Sus scrofa (pig), Jaculus jaculus (jerboa), and Mustela putorius furo (weasel) may be more 
suitable model organisms than rodents.  
 Verification and Benchmarking of ASAP2 Results 
 Based on the premise that mitochondrial genes evolve at a distinguishable rate between 
different species (implying that phylogenetic analyses of mtDNA genes often recapitulate 
taxonomy) (Brown & George, 1979; Kocher et al., 1989), this study explored whether the AD 
gene clustering might be meaningful relative to taxonomy (thus implying evolutionary 
conservation of clustered genes). This strategy for benchmarking the ASAP2 analysis of AD 
genes using mitochondrial DNA sequences reinforces the principle that SA techniques may be 
used to study deviations in evolutionary conservation among isolated genes. In this study, ASAP2 
revealed that the included mitochondrial genes showed a pattern of clustering (based on RF’ 
values) that was highly similar to the clustering of a subset of AD genes that could potentially be 
involved in previously unpredicted relationships via metabolic stress pathways. While this does 
not definitively prove that a causal relationship exists between the aforementioned AD genes, it 
does demonstrate that ability of ASAP2 to highlight possible relationships of interest for complex 
disease genes that might warrant further investigation.  
 
Conclusion 
 Phylogenomic studies using Simultaneous Analysis techniques are positioned to become 
more commonplace as increasing amounts of genomic data are available across the spectrum of 
life and systematically available through resources such as GenBank. Here, an automated tool 
(ASAP2) is presented with the intent of enabling researchers to leverage these data to support 
studies that aim to unveil potentially significant relationships that may be embedded in co-
evolution. The application of ASAP2 to a set of nine genes associated with Alzheimer Disease 
demonstrated a potentially important clustering of genes around components of oxidative stress 
pathways.  
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